At the news
? NEUTRALIMPACT 5/10 CLUSTER filed Mar 16, 2026 at 16:31 ET
United Therapeutics insiders executed a cluster of transactions over the past week, led by CEO Martine Rothblatt and other executives, primarily involving the exercise of derivative securities and tax-related share withholdings. The total value of open-market sales and tax withholding disposals exceeds $15.5 million, with the majority tied to non-cash exercises and tax settlements rather than discretionary selling.
- CEO Martine Rothblatt exercised over 100,000 derivative shares in multiple tranches, mostly at $0 cost, and sold 1,009 shares for $537,203 in open-market transactions.
- CFO James Edgemond and COO Michael Benkowitz each surrendered shares for tax withholding totaling $2.51M and $4.20M respectively after exercising derivatives.
- CEO Rothblatt surrendered 13,637 shares for tax withholding, valued at $7.31 million.
- Total value of share disposals (including tax withholding and open-market sales) exceeds $15.5 million over the 7-day period.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access